CSIMarket
 


Gelesis Holdings Inc   (GLS)
Other Ticker:  
 
 

GLS's Revenue Growth by Quarter and Year

Gelesis Holdings Inc 's Revenue results by quarter and year




GLS Revenue (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - 2.63 0.00 0.00
III Quarter September - 6.65 0.00 0.00
II Quarter June 1.11 8.97 0.00 0.00
I Quarter March 1.75 7.51 0.00 0.00
FY   2.86 25.76 0.00 0.00



GLS Revenue second quarter 2023 Y/Y Growth Comment
Gelesis Holdings Inc reported drop in Revenue in the second quarter 2023 by -87.66% to $ 1.11 millions, from the same quarter in 2022.
This represents worst decline in recent Company history.

Looking into second quarter 2023 results within Major Pharmaceutical Preparations industry 239 other companies have achieved higher Revenue growth. While Gelesis Holdings Inc ' s Revenue meltdown of -87.66% ranks overall at the positon no. 4018 in the second quarter 2023.




GLS Revenue ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June -87.66 % - - -
I Quarter March -76.7 % - - -
FY   - - - -

Financial Statements
Gelesis Holdings Inc 's second quarter 2023 Revenue $ 1.11 millions GLS's Income Statement
Gelesis Holdings Inc 's second quarter 2022 Revenue $ 8.97 millions Quarterly GLS's Income Statement
New: More GLS's historic Revenue Growth >>


GLS Revenue (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - -60.45 % - -
III Quarter September - -25.86 % - -
II Quarter June -36.74 % 19.44 % - -
I Quarter March -33.46 % - - -
FY (Year on Year)   - - - -




Revenue second quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #240
Healthcare Sector #625
Overall #4018

Revenue Y/Y Growth Statistics
High Average Low
-76.67 % -82.17 % -87.66 %
(Mar 31 2023)   (Jun 30 2023)
Revenue second quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #240
Healthcare Sector #625
Overall #4018
Revenue Y/Y Growth Statistics
High Average Low
-76.67 % -82.17 % -87.66 %
(Mar 31 2023)   (Jun 30 2023)

Revenue by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Gelesis Holdings Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
19.42 % -27.42 % -60.49 %
(Jun 30 2022)  


GLS's II. Quarter Q/Q Revenue Comment
In the II. Quarter 2023 Gelesis Holdings Inc reported fall in Revenue from the first quarter by -36.74% to $ 1.11 millions, from $ 1.75 millions achived in the previous quarter.

Some cyclical circumstance which usually elevate II. Quarter 2023 performance, could not rescue the II. Quarter for the Gelesis Holdings Inc , Ella  Thompson, Healthcare sector insider wrote and mentioned that average sequential Revenue growth is at -27.42% for Gelesis Holdings Inc .

Within Major Pharmaceutical Preparations industry 207 other companies have achieved higher Revenue quarter on quarter growth. While Gelesis Holdings Inc 's Revenue growth quarter on quarter, overall rank is 3409.


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #208
Healthcare Sector #564
Overall #3409
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #208
Healthcare Sector #564
Overall #3409
Revenue Q/Q Growth Statistics
High Average Low
19.42 % -27.42 % -60.49 %
(Jun 30 2022)  


GLS's II. Quarter Q/Q Revenue Comment
In the II. Quarter 2023 Gelesis Holdings Inc reported fall in Revenue from the previous quarter by -36.74% to $ 1.11 millions, from $ 1.75 millions released a quarter before.

Although cyclical factors which commonly fuel II. Quarter 2023 Revenue, that simply has not been enough to recover Major Pharmaceutical Preparations's company outcome, Ella  Thompson, Healthcare sector insider pointed out.

Within Major Pharmaceutical Preparations industry 207 other companies have achieved higher Revenue quarter on quarter growth. While Gelesis Holdings Inc 's Revenue growth quarter on quarter, overall rank is 3409.


Gelesis Holdings Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
Cumulative Revenue 12 Months Ending $ 12.14 $ 20.01 $ 25.77 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) - - - - -
Year on Year Revenue Growth Overall Ranking # # # # #
Seqeuential Revenue Change (TTM) -39.32 % -22.36 % - - -
Seq. Revenue Growth (TTM) Overall Ranking # 2955 # 3287 # 0 # 0 # 0




Cumulative Revenue growth Comment


Gelesis Holdings Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 159
Sector # 446
S&P 500 # 2955
Cumulative Revenue growth Comment


Gelesis Holdings Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 159
Sector # 446
S&P 500 # 2955




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
GLS's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for GLS's Competitors
Revenue Growth for Gelesis Holdings Inc 's Suppliers
Revenue Growth for GLS's Customers

You may also want to know
GLS's Annual Growth Rates GLS's Profitability Ratios GLS's Asset Turnover Ratio GLS's Dividend Growth
GLS's Roe GLS's Valuation Ratios GLS's Financial Strength Ratios GLS's Dividend Payout Ratio
GLS's Roa GLS's Inventory Turnover Ratio GLS's Growth Rates GLS's Dividend Comparisons



Companies with similar Revenue fall for the quarter ending Jun 30 2023 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2023
Aquestive Therapeutics Inc -0.18%$ -0.181 millions
Phibro Animal Health Corporation-0.34%$ -0.340 millions
Procyon Corporation-0.59%$ -0.589 millions
Amedisys Inc -0.88%$ -0.882 millions
Baxter International Inc -1.04%$ -1.041 millions
Healthcare Services Group Inc -1.39%$ -1.395 millions
Bio rad Laboratories Inc -1.54%$ -1.536 millions
Harvard Bioscience Inc-1.83%$ -1.832 millions
Embecta Corp -1.92%$ -1.924 millions
Enhabit Inc -2.13%$ -2.127 millions
Icu Medical Inc-2.26%$ -2.260 millions
Tandem Diabetes Care Inc -2.26%$ -2.261 millions
West Pharmaceutical Services Inc -2.27%$ -2.269 millions
Coherus Biosciences inc -2.39%$ -2.386 millions
Hookipa Pharma inc -2.44%$ -2.440 millions
Biolife Solutions Inc -2.53%$ -2.529 millions
Enanta Pharmaceuticals Inc-3.01%$ -3.014 millions
National Research Corporation-3.03%$ -3.033 millions
Intellia Therapeutics Inc -3.11%$ -3.108 millions
Orgenesis Inc -3.14%$ -3.138 millions
Organogenesis Holdings Inc -3.36%$ -3.365 millions
Marker Therapeutics inc -3.52%$ -3.523 millions
Akumin Inc -3.79%$ -3.793 millions
Endo International Plc-3.91%$ -3.912 millions
Zimvie Inc -4.12%$ -4.122 millions
Integra Lifesciences Holdings Corp-4.16%$ -4.160 millions
Universal Biosensors Inc -4.18%$ -4.177 millions
Sonendo Inc -4.26%$ -4.257 millions
Avinger Inc -4.27%$ -4.268 millions
Fuse Medical Inc -4.27%$ -4.271 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com